Finance

Lists
524632:BOM
Shukra Pharmaceuticals Ltd
₹67,00
+0,30%
(+0,20) 1D
14 Okt., 15:30:00 GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for 524632...
Open
₹66,07
High
₹68,80
Low
₹66,07
Mkt. cap
29,64 mjd
Avg. vol.
641,04 k
Volume
284,04 k
P/E ratio
85,91
52-wk high
₹75,50
52-wk low
₹26,30
EPS
₹0,78
No. of employees
211
Open
₹66,07
High
₹68,80
Low
₹66,07
Mkt. cap
29,64 mjd
Avg. vol.
641,04 k
Volume
284,04 k
P/E ratio
85,91
52-wk high
₹75,50
52-wk low
₹26,30
EPS
₹0,78
No. of employees
211
News stories
From web sources and news partners
About Shukra Pharmaceuticals Ltd
CEO-
Employees211
Founded1993
Headquarters-
SectorPharmaceutical industry
Last report
12 Aug. 2026
Fiscal period
Q1 2027
- / -
Revenue / Est. (INR)
235,22 m / -
Fiscal Q1 2027 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in INR
Loading Previous Earnings...
Revenue
Net income
All values in INR
Sep. 2025
Des. 2025
Mrt. 2026
Jun. 2026
Revenue
75,90 m
391,35 m
63,24 m
235,22 m
Cost of goods sold
20,05 m
71,34 m
59,40 m
-15,35 m
Cost of revenue
20,05 m
71,34 m
59,40 m
-15,35 m
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
21,93 m
26,47 m
3,72 m
43,89 m
Operating expense
51,02 m
48,88 m
-2,56 m
64,56 m
Total operating expenses
71,07 m
120,22 m
56,84 m
49,21 m
Operating income
4,83 m
271,13 m
6,40 m
186,01 m
Other non operating income
1,00 k
1,00 k
1,00 k
-
EBT including unusual items
1,98 m
268,31 m
3,82 m
181,72 m
EBT excluding unusual items
1,98 m
268,31 m
3,82 m
181,72 m
Income tax expense
-21,80 m
64,67 m
20,98 m
52,13 m
Effective tax rate
-1 098,04%
24,10%
549,74%
28,69%
Other operating expenses
20,99 m
14,02 m
-16,35 m
9,85 m
Net income
23,78 m
203,65 m
-17,16 m
129,58 m
Net profit margin
31,33%
52,04%
-27,14%
55,09%
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-2,85 m
-2,82 m
-2,58 m
-4,30 m
Net interest expenses
-2,85 m
-2,82 m
-2,58 m
-4,30 m
Depreciation and amortization charges
8,09 m
8,39 m
10,08 m
10,82 m
EBITDA
12,82 m
278,64 m
15,00 m
194,62 m
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google-programme